BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$961.30 MCurrent assets$3.02 BLiabilities$3.08 BAssets$10.25 BNon-current liabilities$2.12 BEquity$7.17 BNon-current assets$7.23 BGross equity(calculated)$8.52 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term investmentsInventoryCash and cash equivalentsAccounts receivable, netPrepaid expensesOther current assetsOther investmentsGoodwill, netProperty, plant and equipment, netPurchased intangibles, netOperating lease right-of-use assetsOther assetsCurrent maturities of long-term debt and notes payableOther current liabilitiesAccrued payroll and employee benefitsAccounts payableIncome and other taxes payableCurrent operating lease liabilitiesDeferred income taxesLong-term debt, net of current maturitiesOther long-term liabilitiesOperating lease liabilitiesRetained earningsAdditional paid-in capitalCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock - Treasury Stock, CommonAccumulated other comprehensive lossCurrent maturities of long-term debt and notes payableCurrent maturities of long-term debt and notes payable$400.70 MShort-term investmentsShort-term investments$1.10 BOther current liabilitiesOther current liabilities$158.80 MCurrent liabilitiesCurrent liabilities$961.30 MCurrent assetsCurrent assets$3.02 BInventoryInventory$780.60 MAccrued payroll and employee benefitsAccrued payroll and employee benefits$150.50 MCash and cash equivalentsCash and cash equivalents$517.00 MAccounts payableAccounts payable$143.50 MLiabilitiesLiabilities$3.08 BAccounts receivable, netAccounts receivable, net$441.80 MIncome and other taxes payableIncome and other taxes payable$74.20 MAssetsAssets$10.25 BPrepaid expensesPrepaid expenses$147.80 MCurrent operating lease liabilitiesCurrent operating lease liabilities$33.60 MOther current assetsOther current assets$31.80 MDeferred income taxesDeferred income taxes$982.20 MNon-current liabilitiesNon-current liabilities$2.12 BLong-term debt, net of current maturitiesLong-term debt, net of current maturities$803.00 MEquityEquity$7.17 BNon-current assetsNon-current assets$7.23 BOther long-term liabilitiesOther long-term liabilities$198.50 MOther investmentsOther investments$5.72 BGross equity (calculated)Gross equity(calculated)$8.52 BOperating lease liabilitiesOperating lease liabilities$133.10 MGoodwill, netGoodwill, net$574.30 MProperty, plant and equipment, netProperty, plant and equipment, net$517.90 MRetained earningsRetained earnings$8.02 BPurchased intangibles, netPurchased intangibles, net$160.00 MOperating lease right-of-use assetsOperating lease right-of-use assets$154.00 MOther assetsOther assets$101.70 MAdditional paid-in capitalAdditional paid-in capital$502.90 MTreasury stock - Treasury Stock, CommonTreasury stock - Treasury Stock, Common−$1.08 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$271.30 M
Chart details

BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
10,252,000,000 US dollars
Current assets
3,020,500,000 US dollars
Non-current assets
7,231,500,000 US dollars
Liabilities
3,078,100,000 US dollars
Current liabilities
961,300,000 US dollars
Non-current liabilities
2,116,800,000 US dollars
Equity
7,173,900,000 US dollars
Short-term investments
1,101,500,000 US dollars
Inventory
780,600,000 US dollars
Cash and cash equivalents
517,000,000 US dollars
Accounts receivable, net
441,800,000 US dollars
Prepaid expenses
147,800,000 US dollars
Other current assets
31,800,000 US dollars
Other investments
5,723,600,000 US dollars
Goodwill, net
574,300,000 US dollars
Property, plant and equipment, net
517,900,000 US dollars
Purchased intangibles, net
160,000,000 US dollars
Operating lease right-of-use assets
154,000,000 US dollars
Other assets
101,700,000 US dollars
Current maturities of long-term debt and notes payable
400,700,000 US dollars
Other current liabilities
158,800,000 US dollars
Accrued payroll and employee benefits
150,500,000 US dollars
Accounts payable
143,500,000 US dollars
Income and other taxes payable
74,200,000 US dollars
Current operating lease liabilities
33,600,000 US dollars
Deferred income taxes
982,200,000 US dollars
Long-term debt, net of current maturities
803,000,000 US dollars
Other long-term liabilities
198,500,000 US dollars
Operating lease liabilities
133,100,000 US dollars
Retained earnings
8,020,600,000 US dollars
Additional paid-in capital
502,900,000 US dollars
Preferred Stock, Value, Issued
0 US dollars
Common stock - Common Class A
0 US dollars
Common stock - Common Class B
0 US dollars
Treasury stock - Treasury Stock, Common
negative 1,078,300,000 US dollars
Accumulated other comprehensive loss
negative 271,300,000 US dollars
Gross equity (calculated)
8,523,500,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!